MedTrace Logo

Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer

NCT00226928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2013-12-04

No results posted yet for this study

Summary

This study will investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic or recurrent breast cancer.

Conditions

  • Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer

Interventions

BEHAVIORAL

Supportive-Expressive Group Therapy plus education

BEHAVIORAL

Education

Sponsors & Collaborators

Principal Investigators

  • David Spiegel, M.D. · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Completion
2005-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00226928 on ClinicalTrials.gov